By Paul Ziobro
Icon plc has launched a new buyback program to repurchase up to $750 million of its shares.
The total value of the authorized share repurchase is now up to $1 billion, the healthcare intelligence and clinical research company said Wednesday.
The new buyback program came as the company reported higher earnings for the fourth-quarter, despite a 1.2% drop in revenue. Chief Executive Steve Cutler said results were in-line with expectation as the company navigates a challenging transition.
Write to Paul Ziobro at paul.ziobro@wsj.com
(END) Dow Jones Newswires
February 19, 2025 17:16 ET (22:16 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.